LIPOCINE INC. Fair Value Adjustment of Warrants
LIPOCINE INC. (LPCN) reported Fair Value Adjustment of Warrants of -$17.17 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-03-10
- LIPOCINE INC. fair value adjustment of warrants for the quarter ending 2024-12-31 was -$3.59K.
- LIPOCINE INC. fair value adjustment of warrants for the quarter ending 2024-09-30 was -$138.08K.
- LIPOCINE INC. fair value adjustment of warrants for the quarter ending 2024-06-30 was $84.43K.
- LIPOCINE INC. fair value adjustment of warrants for the quarter ending 2024-03-31 was $40.07K.
- LIPOCINE INC. fair value adjustment of warrants for fiscal 2024 was -$17.17K.
- LIPOCINE INC. fair value adjustment of warrants for fiscal 2023 was -$212.69K.
- LIPOCINE INC. fair value adjustment of warrants for fiscal 2022 was -$565.94K.
- LIPOCINE INC. fair value adjustment of warrants for fiscal 2021 was -$355.89K, a 112.31% decline from fiscal 2020.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month | Fair Value Adjustment of Warrants 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | -$3.59K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$141.67K derived: sum of 2 quarters · filed 2026-03-10 | -$57.24K derived: sum of 3 quarters · filed 2026-03-10 | -$17.17K 10-K · filed 2026-03-10 | |
| 2024-09-30 | -$138.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$53.65K derived: sum of 2 quarters · filed 2025-11-06 | -$13.58K 10-Q · filed 2025-11-06 | -$25.85K derived: sum of 4 quarters · filed 2025-11-06 | |
| 2024-06-30 | $84.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $124.50K 10-Q · filed 2025-08-05 | $112.23K derived: sum of 3 quarters · filed 2025-08-05 | $37.40K derived: sum of 4 quarters · filed 2025-08-05 | |
| 2024-03-31 | $40.07K 10-Q · filed 2025-05-08 | $27.80K derived: sum of 2 quarters · filed 2025-05-08 | -$47.03K derived: sum of 3 quarters · filed 2025-05-08 | -$74.48K derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | -$12.27K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$87.10K derived: sum of 2 quarters · filed 2025-03-13 | -$114.56K derived: sum of 3 quarters · filed 2025-03-13 | -$212.69K 10-K · filed 2025-03-13 | |
| 2023-09-30 | -$74.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$102.28K derived: sum of 2 quarters · filed 2024-11-07 | -$200.42K 10-Q · filed 2024-11-07 | -$234.66K derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | -$27.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$125.59K 10-Q · filed 2024-08-08 | -$159.83K derived: sum of 3 quarters · filed 2024-08-08 | -$486.07K derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | -$98.13K 10-Q · filed 2024-05-09 | -$132.38K derived: sum of 2 quarters · filed 2024-05-09 | -$458.62K derived: sum of 3 quarters · filed 2024-05-09 | -$1.04M derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | -$34.24K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$360.48K derived: sum of 2 quarters · filed 2024-03-07 | -$943.93K derived: sum of 3 quarters · filed 2024-03-07 | -$565.94K 10-K · filed 2024-03-07 | |
| 2022-09-30 | -$326.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$909.69K derived: sum of 2 quarters · filed 2023-11-08 | -$531.70K 10-Q · filed 2023-11-08 | -$381.38K derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | -$583.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$205.46K 10-Q · filed 2023-08-10 | -$55.14K derived: sum of 3 quarters · filed 2023-08-10 | -$535.09K derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | $377.99K 10-Q · filed 2023-05-11 | $528.31K derived: sum of 2 quarters · filed 2023-05-11 | $48.36K derived: sum of 3 quarters · filed 2023-05-11 | -$172.97K derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $150.32K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | -$329.63K derived: sum of 2 quarters · filed 2023-03-10 | -$550.96K derived: sum of 3 quarters · filed 2023-03-10 | -$355.89K 10-K · filed 2023-03-10 | |
| 2021-09-30 | -$479.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$701.27K derived: sum of 2 quarters · filed 2022-11-09 | -$506.21K 10-Q · filed 2022-11-09 | -$640.02K derived: sum of 4 quarters · filed 2022-11-09 | |
| 2021-06-30 | -$221.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$26.26K 10-Q · filed 2022-08-08 | -$160.06K derived: sum of 3 quarters · filed 2022-08-08 | -$300.54K derived: sum of 4 quarters · filed 2022-08-08 | |
| 2021-03-31 | $195.06K 10-Q · filed 2022-05-09 | $61.26K derived: sum of 2 quarters · filed 2022-05-09 | -$79.22K derived: sum of 3 quarters · filed 2022-05-09 | $1.99M derived: sum of 4 quarters · filed 2022-05-09 | |
| 2020-12-31 | -$133.81K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | -$274.29K derived: sum of 2 quarters · filed 2022-03-09 | $1.79M derived: sum of 3 quarters · filed 2022-03-09 | $2.89M 10-K · filed 2022-03-09 | |
| 2020-09-30 | -$140.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.93M derived: sum of 2 quarters · filed 2021-11-10 | $3.03M 10-Q · filed 2021-11-10 | $2.79M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $2.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $3.17M 10-Q · filed 2021-08-05 | $2.93M derived: sum of 3 quarters · filed 2021-08-05 | $2.93M derived: sum of 4 quarters · filed 2021-08-05 | |
| 2020-03-31 | $1.10M 10-Q · filed 2021-05-06 | $863.63K derived: sum of 2 quarters · filed 2021-05-06 | $863.63K derived: sum of 3 quarters · filed 2021-05-06 | $863.63K derived: sum of 4 quarters · filed 2021-05-06 | |
| 2019-12-31 | -$236.40K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$236.40K derived: sum of 2 quarters · filed 2021-03-11 | -$236.40K derived: sum of 3 quarters · filed 2021-03-11 | -$236.40K 10-K · filed 2021-03-11 | $236.40K 10-K · filed 2020-03-13 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $0.00 derived: sum of 2 quarters · filed 2020-11-10 | $0.00 10-Q · filed 2020-11-10 | ||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |